Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy

D Duan - Molecular Therapy, 2018 - cell.com
Duchenne muscular dystrophy (DMD) is a lethal muscle disease caused by dystrophin gene
mutation. Conceptually, replacing the mutated gene with a normal one would cure the …

Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy

JW McGreevy, CH Hakim… - Disease models & …, 2015 - journals.biologists.com
Duchenne muscular dystrophy (DMD) is a progressive muscle-wasting disorder. It is caused
by loss-of-function mutations in the dystrophin gene. Currently, there is no cure. A highly …

Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy

L Amoasii, JCW Hildyard, H Li, E Sanchez-Ortiz… - Science, 2018 - science.org
Mutations in the gene encoding dystrophin, a protein that maintains muscle integrity and
function, cause Duchenne muscular dystrophy (DMD). The deltaE50-MD dog model of DMD …

Eteplirsen treatment for Duchenne muscular dystrophy: exon skipping and dystrophin production

JS Charleston, FJ Schnell, J Dworzak, C Donoghue… - Neurology, 2018 - AAN Enterprises
Objective To describe the quantification of novel dystrophin production in patients with
Duchenne muscular dystrophy (DMD) after long-term treatment with eteplirsen. Methods …

Safety, tolerability, and efficacy of viltolarsen in boys with Duchenne muscular dystrophy amenable to exon 53 skipping: a phase 2 randomized clinical trial

PR Clemens, VK Rao, AM Connolly, AD Harper… - JAMA …, 2020 - jamanetwork.com
Importance An unmet need remains for safe and efficacious treatments for Duchenne
muscular dystrophy (DMD). To date, there are limited agents available that address the …

Dystrophin and mutations: one gene, several proteins, multiple phenotypes

F Muntoni, S Torelli, A Ferlini - The Lancet Neurology, 2003 - thelancet.com
A large and complex gene on the X chromosome encodes dystrophin. Many mutations have
been described in this gene, most of which affect the expression of the muscle isoform, the …

Theoretic applicability of antisense‐mediated exon skipping for Duchenne muscular dystrophy mutations

A Aartsma‐Rus, I Fokkema, J Verschuuren… - Human …, 2009 - Wiley Online Library
Antisense‐mediated exon skipping aiming for reading frame restoration is currently a
promising therapeutic application for Duchenne muscular dystrophy (DMD). This approach …

Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading‐frame rule

A Aartsma‐Rus, JCT Van Deutekom… - Muscle & Nerve …, 2006 - Wiley Online Library
The severe Duchenne and milder Becker muscular dystrophy are both caused by mutations
in the DMD gene. This gene codes for dystrophin, a protein important for maintaining the …

A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy

JR Mendell, Z Sahenk, V Malik, AM Gomez… - Molecular Therapy, 2015 - cell.com
Becker muscular dystrophy (BMD) is a variant of dystrophin deficiency resulting from DMD
gene mutations. Phenotype is variable with loss of ambulation in late teenage or late mid-life …

The importance of genetic diagnosis for Duchenne muscular dystrophy

A Aartsma-Rus, IB Ginjaar, K Bushby - Journal of medical genetics, 2016 - jmg.bmj.com
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy are caused by
mutations in the dystrophin-encoding DMD gene. Large deletions and duplications are most …